|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 67.21 USD | -0.18% |
|
-1.67% | -3.24% |
| 07-31 | UBS Adjusts Exponent Price Target to $72 From $75, Maintains Neutral Rating | MT |
| 07-31 | Exponent, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 84 | +24.98% | 3 | ||||||
| 216.31 | +7.35% | 16 | ||||||
| 162.53 | +14.58% | 15 | ||||||
| 32.44 | +16.6% | 17 | ||||||
| 58.97 | +0.81% | 12 | ||||||
| 24.28 | +15.47% | 12 | ||||||
| 318.08 | +13.68% | 12 | ||||||
| 42.18 | +20.04% | 11 | ||||||
| 44.62 | +26.56% | 8 | ||||||
| 73.5 | +11.7% | 8 | ||||||
| - | 273.33 | -0.49% | 3 | |||||
| 75 | +8.6% | 14 | ||||||
| 150.5 | +34.4% | 2 | ||||||
| 1,350 | +10.97% | 5 | ||||||
| 2.091 | +0.03% | 8 | ||||||
| - | 50.2 | +7.68% | 2 | |||||
| 3.138 | +26.41% | 12 | ||||||
| - | 92.5 | +62.51% | 2 | |||||
| 55.93 | +13.15% | 7 | ||||||
| Average | 163.66 | +16.58% | 9 | ||||||
| Weighted average by Cap. | 171.89 | +11.82% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
